An ongoing shortage of medication for attention deficit hyperactivity disorder is affecting millions—and with no end in sight. The Food and Drug Administration first announced a shortage of Adderall, ...
The Drug Enforcement Administration has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in ...
“To give children with ADHD the best chance to thrive, I believe families, medical professionals, and educators should focus on behavioral and academic interventions first and add medication only if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback